PP_1170x120_10-25-21

telmisartan tablets

FDA gives OK to new Aurobindo generics

FDA gives OK to new Aurobindo generics

DAYTON, N.J. — Aurobindo Pharma Ltd. has received approval from the Food and Drug Administration for gemfibrozil tablets, omeprazole delayed-release capsules and telmisartan tablets. The company said Monday that its gemfibrozil tablets (600 mg) are a generic version of Lopid tablets from Pfizer Inc. The medication is indicated as an adjunctive therapy to diet for

Adheris Health